SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Summit Corporation Release: Repeat Dosing of SMT C1100 for Treatment of Duchenne Muscular Dystrophy Meets Endpoints in Phase 1 Clinical Trial